Track topics on Twitter Track topics that are important to you
The goal of this study is to evaluate the comparative efficacy and safety of three different doses ( 110 mg, 150 mg, 220 mg) of BIBR 1048 (Dabigatran etexilate) orally, compared to placebo, in preventi on of venous thromboembolism in patient with primary elective total knee replacement surgery, and to evaluate dose-response.
This is a double-blind, multi-centre, randomized, parallel-group placebo-controlled study to evaluat e the efficacy and safety of BIBR 1048 (Dabigatran etexilate) oral administration, as well as its do se-response, in preventing venous thromboembolism (deep vein thrombosis and pulmonary embolism) in p atients with elective total knee replacement surgery. There are three administration groups in total
, the BIBR 1048 110 mg, 150 mg and 220 mg once daily administration groups and the placebo group, wi th 100 cases in each group (total of 400 cases), and the study drug will be randomly allocated to pa tients in each group. The administration period is 11-14 days after total knee replacement surgery, and the study drug will be given once daily.
This trial aims is to demonstrate the effectiveness of BIBR 1048 (Dabigatran ete xilate), compared with placebo, in prevention of venous thromboembolism in patie nts with primary elective total knee replacement surgery. For the primary endpoi nt (total VTE and all cause mortality), superiority of BIBR 1048 (Dabigatran ete xilate) to placebo will be tested.
For the primary comparison the rates of total venous thromboemobolism events (VT E) and all-cause mortality during the treatment period will be compared.
Allocation: Randomized, Control: Placebo Control, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Prevention
Arthroplasty, Replacement, Knee
110 mg capsule (110 mg capsule + placebo capsule), 150 mg capsule (75 mg capsule x 2), 220 mg capsule (110 mg capsule x 2)
Boehringer Ingelheim Investigational Site
Boehringer Ingelheim Pharmaceuticals
Published on BioPortfolio: 2014-07-23T21:47:17-0400
The purpose of this study is to test the expression of microRNAs related to the syndromes after the intervention of Tongguan capsule,preliminarily to investigate the mechanism of the effec...
The objective of this study is to compare the rate and extent of absorption of Ramipril 10 mg capsule (test) versus Altace® (reference), administered as 1 x 10 mg capsule under fed condit...
The objective of this study is to compare the rate and extent of absorption of Ramipril 10 mg capsule (test) versus Altace® (reference) administered as the content of 1 x 10 mg capsule mi...
The purpose of this study is to determine the missing rate of capsule endoscopy using back-to-back capsule endoscopy.
The objective of this study is to compare the rate and extent of absorption of ramipril 10 mg capsule (test) versus Altace® (reference), administered as 1 x 10 mg capsule under fasting co...
In this paper, we propose a new measurement and compensation method for the eccentricity of the inertial confinement fusion (ICF) capsule, which combines computer vision and the laser differential con...
Diagnostic yield of Small Bowel Capsule Endoscopy (SBCE) for the assessment of small bowel (SB) lesions is higher than radiologic imaging techniques. However, magnetic resonance enterography (MRE) dat...
To evaluate efficacy of denervation of the of the hip joint capsule (HJC), as a treatment of hip joint pain. Specifically, we tested the hypothesis that HJC denervation will significantly reduce the n...
The aim of this study was to evaluate preoperatively identifiable clinical and ultrasonographic characteristics associated with central lymph node metastasis (CLNM) in clinically node negative papilla...
A novel catalytical feature of the hexameric resorcinarene capsule (C) is here highlighted. The self-assembled cage C has been exploited to promote a mild Friedel-Crafts benzylation of several arenes ...
Clouding or loss of transparency of the posterior lens capsule, usually following CATARACT extraction.
Non-invasive, endoscopic imaging by use of VIDEO CAPSULE ENDOSCOPES to perform examination of the gastrointestinal tract, especially the small bowel.
A pill sized videocamera encased in a capsule. It is designed to be swallowed and subsequently traverse the gastrointestinal tract while transmitting diagnostic images along the way.
The sac enclosing a joint. It is composed of an outer fibrous articular capsule and an inner SYNOVIAL MEMBRANE.
Procedures performed to remove CAPSULE OPACIFICATION that develops on the POSTERIOR CAPSULE OF THE LENS following removal of a primary CATARACT.